DEVELOPMENT AND VALIDATION OF A DECISION AID FOR CHOOSING AMONG ANTITHROMBOTIC AGENTS FOR ATRIAL FIBRILLATION

2016 ◽  
Vol 32 (10) ◽  
pp. S279
Author(s):  
S. Fatima ◽  
A. Holbrook ◽  
S. Schulman ◽  
G. Curnew ◽  
S. Park ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Decision Aid ◽  
Antithrombotic Agents ◽  
Development And Validation

Development and validation of a decision aid for choosing among antithrombotic agents for atrial fibrillation

2016 ◽  
Vol 145 ◽  
pp. 143-148 ◽  
Author(s):  
Safoora Fatima ◽  
Anne Holbrook ◽  
Sam Schulman ◽  
Steve Park ◽  
Sue Troyan ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Decision Aid ◽  
Antithrombotic Agents ◽  
Development And Validation

Use of an Atrial Fibrillation Medication Decision Aid Improves Knowledge and Process for Decision Making (Preprint)

2018 ◽  
Author(s):  
Molly Beinfeld ◽  
Suzanne Brodney ◽  
Michael Barry ◽  
Erika Poole ◽  
Adam Kunin
Keyword(s):  
Atrial Fibrillation ◽  
Decision Making ◽  
Shared Decision Making ◽  
Anticoagulant Therapy ◽  
Decision Aid ◽  
Response Rate ◽  
Intervention Group ◽  
Shared Decision ◽  
Community Based ◽  
Baseline Group

BACKGROUND A rural community-based Cardiology practice implemented shared decision making supported by an evidence-based decision aid booklet to improve the quality of anticoagulant therapy decisions in patients with atrial fibrillation. OBJECTIVE To develop a practical workflow for implementation of an anticoagulant therapy decision aid and to assess the impact on patients’ knowledge and process for anticoagulant medication decision making. METHODS The organization surveyed all patients with atrial fibrillation being seen at Copley Hospital to establish a baseline level of knowledge, certainty about the decision and process for decision making. The intervention surveys included the same knowledge, certainty, process and demographic questions as the baseline surveys, but also included questions asking for feedback on the decision aid booklet. Stroke risk scores (CHA2DS2-VASc score) were calculated by Copley staff for both groups using EMR data. RESULTS We received 46 completed surveys in the baseline group (64% response rate) and 50 surveys in the intervention group (72% response rate). The intervention group had higher knowledge score than the baseline group (3.6 out of 4 correct answers vs 3.1, p=0.036) and Decision Process Score (2.89 out of 4 vs 2.09, p=0.0023) but similar scores on the SURE scale (3.12 out of 4 vs 3.17, p=0.79). Knowledge and Process score differences were sustained even after adjusting for co-variates in stepwise linear regression analyses. Patients with high school or lower education appeared to benefit the most from shared decision making, as demonstrated by their knowledge scores. CONCLUSIONS It is feasible and practical to implement shared decision making supported by decision aids in a community-based Cardiology practice. Shared decision making can improve knowledge and process for decision making for patients with atrial fibrillation. CLINICALTRIAL None

A Novel Biomarker Model for Detecting Patients With Atrial Fibrillation: A Development and Validation Study

2021 ◽  
Author(s):  
Winnie Chua ◽  
Victor Roth Cardoso ◽  
Eduard Guasch ◽  
Moritz F. Sinner ◽  
Paul Brady ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Validation Study ◽  
Development And Validation

Development and validation of a risk score to predict 30-day mortality in patients with atrial fibrillation-related stroke: GPS-GF score

2018 ◽  
Vol 40 (7) ◽  
pp. 534-542 ◽  
Author(s):  
Hua Gao ◽  
Xiaolong Sun ◽  
Wen Li ◽  
Qiong Gao ◽  
Jing Zhang ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Risk Score ◽  
Development And Validation

scholarly journals Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation

2019 ◽  
Vol 15 (1) ◽  
pp. 49-53
Author(s):  
V. I. Petrov ◽  
O. V. Shatalova ◽  
A. S. Gerasimenko ◽  
V. S. Gorbatenko
Keyword(s):  
Atrial Fibrillation ◽  
High Risk ◽  
Anticoagulant Therapy ◽  
Vitamin K Antagonists ◽  
Oral Anticoagulants ◽  
Direct Oral Anticoagulants ◽  
Thromboembolic Complications ◽  
Antithrombotic Agents ◽  
Cardiology Department ◽  
Number Of Patients

Aim. To study the frequency of prescribing antithrombotic agents in patients with non-valvular atrial fibrillation (AF) who were hospitalized in the cardiology department of a multidisciplinary hospital.Material and methods. A retrospective one-time study of medical records of 765 patients with non-valvular AF treated in the cardiology department of a multidisciplinary hospital in 2012 and 2016 was performed.Results. All patients were stratified in three groups depending on the CHA2DS2-VASc score. The frequency of prescribing antithrombotic agents was evaluated in each group. A low risk of thromboembolic complications was found in 1% (n=3) of patients in 2012 and 0.6% (n=3) in 2016. All these patients received antithrombotic agents. CHA2DS2-VASc=1 was found in 6% (n=15) of patients with AF in 2012 and in 3.4% (n=17) in 2016. A significant number of patients in this group received anticoagulant therapy with vitamin K antagonists (warfarin) or with direct oral anticoagulants. A high risk of thromboembolic complications (CHA2DS2-VASc≥2) was found in 93% of patient (n=245) in 2012 and in 96% (n=482) in 2016. Anticoagulant therapy was prescribed in 70.2% (n=172) patients with high risk in 2012 and 80% (n=387) in 2016. However, some patients with high risk of thromboembolic complications did not have the necessary therapy.Conclusion. Positive changes in the structure and frequency of prescribing anticoagulant drugs in patients with AF and a high risk of thromboembolic complications were found during the years studied. 

scholarly journals Systematic Fluid Assessment in Haemodialysis: Development and Validation of A Decision Aid

2019 ◽  
Vol 46 (1) ◽  
pp. 52-61
Author(s):  
Jenny Stenberg ◽  
David Keane ◽  
Magnus Lindberg ◽  
Hans Furuland
Keyword(s):  
Decision Aid ◽  
Fluid Assessment ◽  
Development And Validation

FP672PREDICTING MORTALITY RISK ON DIALYSIS AND CONSERVATIVE CARE; DEVELOPMENT AND VALIDATION OF A DECISION AID FOR PRE-DIALYSIS PATIENTS

2019 ◽  
Vol 34 (Supplement_1) ◽  
Author(s):  
Chava Ramspek ◽  
Wouter Verberne ◽  
Friedo Dekker ◽  
Willem Jan Bos ◽  
Merel Van Diepen ◽  
...  
Keyword(s):  
Mortality Risk ◽  
Decision Aid ◽  
Dialysis Patients ◽  
Conservative Care ◽  
Development And Validation ◽  
Care Development

Development and Validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in Patients With Atrial Fibrillation

2011 ◽  
Vol 4 (1) ◽  
pp. 15-25 ◽  
Author(s):  
John Spertus ◽  
Paul Dorian ◽  
Rosemary Bubien ◽  
Steve Lewis ◽  
Donna Godejohn ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Atrial Fibrillation ◽  
Development And Validation
Sign in / Sign up

Export Citation Format

Share Document